Company / R&D per Share
Masimo R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.36
FY2025
5-year range
$2.36 / $3.46
FY2021-FY2025
Trend
-31.7%
vs FY2024
Sector context
#37 of 108
Health Care
What the data says
At $2.36, Masimo's r&d per share ranks #37 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $1.12 in FY2018 to $3.46 in FY2022.
Based on SEC 10-K filings.
2.36 in FY2025 with a 5-year CAGR of +1.3%.
Declined from $2.49 to $2.36 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -12.0%
- 5-Year CAGR
- +1.3%
- 10-Year CAGR
- -
Sector benchmark
#37 of 108 in Health CareTop 34% of 108This company $2.36 Sector average $2.07
▼
+13.7% above sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 31.7% year-over-year.
- Ranks #37 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.36 | -31.7% |
| FY2024 | $3.45 | +38.8% |
| FY2023 | $2.49 | -28.2% |
| FY2022 | $3.46 | +39.4% |
| FY2021 | $2.48 | +12.3% |
| FY2020 | $2.21 | +79.9% |
| FY2019 | $1.23 | +10.0% |
| FY2018 | $1.12 | -14.1% |
| FY2017 | $1.30 | +14.6% |
| FY2016 | $1.13 | +7.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026